STUDYING TREATMENTS FOR AIDS - NEW CHALLENGES FOR CLINICAL-TRIALS - A PANEL DISCUSSION AT THE 1990 ANNUAL-MEETING OF THE SOCIETY-FOR-CLINICAL-TRIALS

被引：5

作者：

ELLENBERG, SS

COOPER, E

EIGO, J

FINKELSTEIN, DM

HOTH, DF

NUSINOFFLEHRMAN, S

SACKS, H

机构：

[1] US FDA,DIV ANTIRETROVIRAL DRUG PROD,ROCKVILLE,MD 20857

[2] ACT UP,COMM TREATMENT & DATA,NEW YORK,NY

[3] HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115

[4] BURROUGHS WELLCOME CO,DEPT INFECT DIS,RES TRIANGLE PK,NC 27709

[5] MT SINAI HOSP,DIV INFECT DIS,NEW YORK,NY

来源：

CONTROLLED CLINICAL TRIALS | 1992年 / 13卷 / 04期

关键词：

D O I：

10.1016/0197-2456(92)90011-N

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：272 / 292

页数：21

共 24 条

[1] DESIGN CONSIDERATIONS FOR AIDS TRIALS [J].

BYAR, DP ;

SCHOENFELD, DA ;

GREEN, SB ;

AMATO, DA ;

DAVIS, R ;

DEGRUTTOLA, V ;

FINKELSTEIN, DM ;

GATSONIS, C ;

GELBER, RD ;

LAGAKOS, S ;

LEFKOPOULOU, M ;

TSIATIS, AA ;

ZELEN, M ;

PETO, J ;

FREEDMAN, LS ;

GAIL, M ;

SIMON, R ;

ELLENBERG, SS ;

ANDERSON, JR ;

COLLINS, R ;

PETO, R ;

PETO, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1343-1348

[2]

Cochran W. G., 1957, EXPT DESIGNS

[3]

DISMUKES W, 1989, FLUCONAZOLE VERSUS A

[4]

EFRON B, 1991, J AM STAT ASSOC, V86, P9, DOI 10.2307/2289707

[5] THE SAFETY AND EFFICACY OF ZIDOVUDINE (AZT) IN THE TREATMENT OF SUBJECTS WITH MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) INFECTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

FISCHL, MA ;

RICHMAN, DD ;

HANSEN, N ;

COLLIER, AC ;

CAREY, JT ;

PARA, MF ;

HARDY, WD ;

DOLIN, R ;

POWDERLY, WG ;

ALLAN, JD ;

WONG, B ;

MERIGAN, TC ;

MCAULIFFE, VJ ;

HYSLOP, NE ;

RHAME, FS ;

BALFOUR, HH ;

SPECTOR, SA ;

VOLBERDING, P ;

PETTINELLI, C ;

ANDERSON, J .

ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) :727-737

[6] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

FISCHL, MA ;

RICHMAN, DD ;

GRIECO, MH ;

GOTTLIEB, MS ;

VOLBERDING, PA ;

LASKIN, OL ;

LEEDOM, JM ;

GROOPMAN, JE ;

MILDVAN, D ;

SCHOOLEY, RT ;

JACKSON, GG ;

DURACK, DT ;

KING, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) :185-191

[7] A RANDOMIZED CONTROLLED TRIAL OF A REDUCED DAILY DOSE OF ZIDOVUDINE IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].

FISCHL, MA ;

PARKER, CB ;

PETTINELLI, C ;

WULFSOHN, M ;

HIRSCH, MS ;

COLLIER, AC ;

ANTONISKIS, D ;

HO, M ;

RICHMAN, DD ;

FUCHS, E ;

MERIGAN, TC ;

REICHMAN, RC ;

GOLD, J ;

STEIGBIGEL, N ;

LEOUNG, GS ;

RASHEED, S ;

TSIATIS, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1009-1014

[8]

GAIL MH, 1990, J ACQ IMMUN DEF SYND, V3, P296

[9] BIOSTATISTICAL CONSIDERATIONS FOR QUALITY ASSESSMENT OF IMMUNOLOGICAL MEASUREMENTS USED IN CLINICAL AND LONGITUDINAL-STUDIES [J].

GELMAN, R ;

EUDEY, L .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 52 (01) :28-37

[10] ISSUES IN THE DESIGN OF DRUG TRIALS FOR AIDS [J].

GREEN, SB ;

ELLENBERG, SS ;

FINKELSTEIN, D ;

FORSYTHE, AB ;

FREEDMAN, LS ;

FREEMAN, K ;

LEFKOPOULOU, M ;

SCHOENFELD, D ;

SMITH, RP .

CONTROLLED CLINICAL TRIALS, 1990, 11 (02) :80-87

← 1 2 3 →